Stocks ELV

Evercore ISI Group Initiates Coverage of Elevance Health (ELV) with In-Line Recommendation

Fintel reports that on April 8, 2026, Evercore ISI Group initiated coverage of Elevance Health (NYSE:ELV) with a In-Line recommendation.

Analyst Price Forecast Suggests 23.36% Upside

As of March 27, 2026, the average one-year price target for Elevance Health is $392.72/share. The forecasts range from a low of $335.32 to a high of $516.02. The average price target represents an increase of 23.36% from its latest reported closing price of $318.36 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Elevance Health is 176,691MM, a decrease of 11.27%. The projected annual non-GAAP EPS is 47.43.

What is the Fund Sentiment?

There are 1,550 funds or institutions reporting positions in Elevance Health. This is an decrease of 953 owner(s) or 38.07% in the last quarter. Average portfolio weight of all funds dedicated to ELV is 0.30%, an increase of 24.82%. Total shares owned by institutions decreased in the last three months by 13.98% to 199,673K shares. ELV / Elevance Health, Inc. Put/Call Ratios The put/call ratio of ELV is 0.71, indicating a bullish outlook.

What are Other Shareholders Doing?

Wellington Management Group Llp holds 8,290K shares representing 3.77% ownership of the company. In its prior filing, the firm reported owning 6,621K shares , representing an increase of 20.13%. The firm increased its portfolio allocation in ELV by 35.99% over the last quarter.

Price T Rowe Associates holds 7,446K shares representing 3.39% ownership of the company. In its prior filing, the firm reported owning 5,839K shares , representing an increase of 21.59%. The firm increased its portfolio allocation in ELV by 39.43% over the last quarter.

Sanders Capital holds 5,751K shares representing 2.62% ownership of the company. In its prior filing, the firm reported owning 5,769K shares , representing a decrease of 0.31%. The firm increased its portfolio allocation in ELV by 1.26% over the last quarter.

Geode Capital Management holds 5,125K shares representing 2.33% ownership of the company. In its prior filing, the firm reported owning 5,144K shares , representing a decrease of 0.38%. The firm increased its portfolio allocation in ELV by 4.65% over the last quarter.

Artisan Partners Limited Partnership holds 5,033K shares representing 2.29% ownership of the company. In its prior filing, the firm reported owning 4,577K shares , representing an increase of 9.06%. The firm increased its portfolio allocation in ELV by 25.91% over the last quarter.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

Fintel
Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.
Check out our Unique Analysis of Insider Sentiment for Elevance Health, Inc. Find out what the Options Markets think of Elevance Health, Inc. See our take on Elevance Health, Inc. Upcoming Earnings More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available